Business Context and Reporting Period
This Form 8-K filing by Bruker BioSciences Corporation (now Bruker Corp) reports a material definitive agreement entered into on August 1, 2006. The filing details modifications to the compensation plan for non-employee directors, effective as of the report date.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to director compensation adjustments:
- Non-Employee Director Annual Retainer: Increased from $16,000 to $26,000.
- Board Meeting Fee: New payment of $1,500 per meeting attended (in-person or telephonically).
- Audit Committee Chairman Retainer: Increased from $18,000 to $28,000.
- Audit Committee Member Retainer: Increased from $12,000 to $18,000.
- Compensation Committee Chairman Retainer: Increased from $6,000 to $13,000.
- Compensation Committee Member Retainer: Increased from $4,000 to $8,000.
Material Changes Versus Prior Period
The primary material change is the significant increase in cash compensation for non-employee directors and committee chairs effective August 1, 2006. The filing notes that employee directors continue to receive compensation solely as employees, and committee members do not receive separate payments for attending committee meetings.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It strictly addresses the entry into a material definitive agreement regarding director compensation. No unusual items were reported.
Investor Verification Checklist
- Verify the total number of non-employee directors to calculate the aggregate impact on annual cash compensation expenses.
- Confirm the frequency of Board meetings to estimate the variable meeting fee liability.
- Review the Company's proxy statement or subsequent filings to determine the annual equity grant amounts for directors, which remain at the discretion of the Compensation Committee.